Bank of Montreal’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-8,400
Closed -$941K 3599
2025
Q1
$941K Buy
+8,400
New +$867K ﹤0.01% 1853
2022
Q2
Sell
-15,000
Closed -$1.27M 4208
2022
Q1
$1.27M Buy
+15,000
New +$959K ﹤0.01% 2185
2019
Q1
Sell
-19,200
Closed -$1.2M 4481
2018
Q4
$1.2M Buy
+19,200
New +$1.34M ﹤0.01% 1797
2018
Q3
Sell
-79,100
Closed -$5.6M 4790
2018
Q2
$5.6M Buy
+79,100
New +$5.59M ﹤0.01% 1115
2017
Q4
Sell
-27
Closed -$2K 4220
2017
Q3
$2K Sell
27
-46
-63% -$3.52K ﹤0.01% 4030
2017
Q2
$5K Buy
+73
New +$4.86K ﹤0.01% 3869
2016
Q4
Sell
-27
Closed -$2K 4104
2016
Q3
$2K Buy
+27
New +$2.19K ﹤0.01% 3848
2015
Q1
Sell
-105,500
Closed -$9.94M 4057
2014
Q4
$9.94M Buy
+105,500
New +$10.9M 0.01% 781

Other funds holding GILD

Bank of Montreal's GILD Position: Q1 2026 in Review

Bank of Montreal increased its Gilead Sciences (GILD) stake by 2.3% in Q1 2026, buying an estimated $11.3M and bringing the position to 3,549,224 shares worth $495M. The position accounts for 0.18% of the portfolio, ranked #97.

Bank of Montreal first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $576M in Q2 2015. 2,316 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Bank of Montreal held 3,549,224 shares of Gilead Sciences worth $495M as of Q1 2026.
  • Bank of Montreal bought 80,430 Gilead Sciences shares in Q1 2026, an estimated $11.3M.
  • Gilead Sciences made up 0.18% of Bank of Montreal's portfolio in Q1 2026, its #97 holding.
  • Bank of Montreal first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • Bank of Montreal's Gilead Sciences position peaked at $576M in Q2 2015.
  • 2,316 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.